Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
To view the full text, please login as a subscribed user or purchase a subscription. Click here to view the full text on ScienceDirect. To gain mechanistic understanding on how metabolism provides a common platform of crosstalk between cancer and immune cells and test the therapeutic potential of combination of sodium phenylbutyrate (SBP) and mTOR inhibition in HCC.
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
